Moreover, HCC cells elevate PKM2 expression by preventing its degradation, as ubiquitin-specific protease 35 (USP35) stabilizes PKM2 through deubiquitination, promoting aerobic glycolysis and tumor progression (48). Here, USP35 is linked to hepatocellular carcinoma.